These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 23280845)

  • 1. Central role and mechanisms of β-cell dysfunction and death in friedreich ataxia-associated diabetes.
    Cnop M; Igoillo-Esteve M; Rai M; Begu A; Serroukh Y; Depondt C; Musuaya AE; Marhfour I; Ladrière L; Moles Lopez X; Lefkaditis D; Moore F; Brion JP; Cooper JM; Schapira AH; Clark A; Koeppen AH; Marchetti P; Pandolfo M; Eizirik DL; Féry F
    Ann Neurol; 2012 Dec; 72(6):971-82. PubMed ID: 23280845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exenatide induces frataxin expression and improves mitochondrial function in Friedreich ataxia.
    Igoillo-Esteve M; Oliveira AF; Cosentino C; Fantuzzi F; Demarez C; Toivonen S; Hu A; Chintawar S; Lopes M; Pachera N; Cai Y; Abdulkarim B; Rai M; Marselli L; Marchetti P; Tariq M; Jonas JC; Boscolo M; Pandolfo M; Eizirik DL; Cnop M
    JCI Insight; 2020 Jan; 5(2):. PubMed ID: 31877117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-sectional analysis of glucose metabolism in Friedreich ataxia.
    Greeley NR; Regner S; Willi S; Lynch DR
    J Neurol Sci; 2014 Jul; 342(1-2):29-35. PubMed ID: 24819921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of genetic severity on glucose homeostasis in Friedreich ataxia.
    Isaacs CJ; Brigatti KW; Kucheruk O; Ratcliffe S; Sciascia T; McCormack SE; Willi SM; Lynch DR
    Muscle Nerve; 2016 Nov; 54(5):887-894. PubMed ID: 27061687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes in Friedreich ataxia.
    Cnop M; Mulder H; Igoillo-Esteve M
    J Neurochem; 2013 Aug; 126 Suppl 1():94-102. PubMed ID: 23859345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unveiling a common mechanism of apoptosis in β-cells and neurons in Friedreich's ataxia.
    Igoillo-Esteve M; Gurgul-Convey E; Hu A; Romagueira Bichara Dos Santos L; Abdulkarim B; Chintawar S; Marselli L; Marchetti P; Jonas JC; Eizirik DL; Pandolfo M; Cnop M
    Hum Mol Genet; 2015 Apr; 24(8):2274-86. PubMed ID: 25552656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel GAA-repeat-expansion-based mouse model of Friedreich's ataxia.
    Anjomani Virmouni S; Ezzatizadeh V; Sandi C; Sandi M; Al-Mahdawi S; Chutake Y; Pook MA
    Dis Model Mech; 2015 Mar; 8(3):225-35. PubMed ID: 25681319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond loss of frataxin: the complex molecular pathology of Friedreich ataxia.
    Evans-Galea MV; Lockhart PJ; Galea CA; Hannan AJ; Delatycki MB
    Discov Med; 2014 Jan; 17(91):25-35. PubMed ID: 24411698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in the determinants of right ventricular and regional left ventricular long-axis dysfunction in Friedreich ataxia.
    Peverill RE; Donelan L; Corben LA; Delatycki MB
    PLoS One; 2018; 13(12):e0209410. PubMed ID: 30596685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GAA repeat expansion mutation mouse models of Friedreich ataxia exhibit oxidative stress leading to progressive neuronal and cardiac pathology.
    Al-Mahdawi S; Pinto RM; Varshney D; Lawrence L; Lowrie MB; Hughes S; Webster Z; Blake J; Cooper JM; King R; Pook MA
    Genomics; 2006 Nov; 88(5):580-90. PubMed ID: 16919418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPAR gamma agonist leriglitazone improves frataxin-loss impairments in cellular and animal models of Friedreich Ataxia.
    Rodríguez-Pascau L; Britti E; Calap-Quintana P; Dong YN; Vergara C; Delaspre F; Medina-Carbonero M; Tamarit J; Pallardó FV; Gonzalez-Cabo P; Ros J; Lynch DR; Martinell M; Pizcueta P
    Neurobiol Dis; 2021 Jan; 148():105162. PubMed ID: 33171227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA Base Damage Repair Crosstalks with Chromatin Structures to Contract Expanded GAA Repeats in Friedreich's Ataxia.
    Lai Y; Diaz N; Armbrister R; Agoulnik I; Liu Y
    Biomolecules; 2024 Jul; 14(7):. PubMed ID: 39062522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional profiling of isogenic Friedreich ataxia neurons and effect of an HDAC inhibitor on disease signatures.
    Lai JI; Nachun D; Petrosyan L; Throesch B; Campau E; Gao F; Baldwin KK; Coppola G; Gottesfeld JM; Soragni E
    J Biol Chem; 2019 Feb; 294(6):1846-1859. PubMed ID: 30552117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Friedreich ataxia: the clinical picture.
    Pandolfo M
    J Neurol; 2009 Mar; 256 Suppl 1():3-8. PubMed ID: 19283344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterozygous expansion of the GAA tract of the X25/frataxin gene is associated with insulin resistance in humans.
    Hebinck J; Hardt C; Schöls L; Vorgerd M; Briedigkeit L; Kahn CR; Ristow M
    Diabetes; 2000 Sep; 49(9):1604-7. PubMed ID: 10969848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA methylation in Friedreich ataxia silences expression of frataxin isoform E.
    Rodden LN; Gilliam KM; Lam C; Rojsajjakul T; Mesaros C; Dionisi C; Pook M; Pandolfo M; Lynch DR; Blair IA; Bidichandani SI
    Sci Rep; 2022 Mar; 12(1):5031. PubMed ID: 35322126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corneal confocal microscopy: Neurologic disease biomarker in Friedreich ataxia.
    Pagovich OE; Vo ML; Zhao ZZ; Petropoulos IN; Yuan M; Lertsuwanroj B; Ciralsky J; Lai E; Kiss S; D'Amico DJ; Mezey JG; Malik RA; Crystal RG
    Ann Neurol; 2018 Dec; 84(6):893-904. PubMed ID: 30294800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A combined nucleic acid and protein analysis in Friedreich ataxia: implications for diagnosis, pathogenesis and clinical trial design.
    Saccà F; Puorro G; Antenora A; Marsili A; Denaro A; Piro R; Sorrentino P; Pane C; Tessa A; Brescia Morra V; Cocozza S; De Michele G; Santorelli FM; Filla A
    PLoS One; 2011 Mar; 6(3):e17627. PubMed ID: 21412413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Friedreich ataxia: Detection of GAA repeat expansions and frataxin point mutations.
    Pandolfo M
    Methods Mol Med; 2006; 126():197-216. PubMed ID: 16930014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variations creating microRNA target sites in the FXN 3'-UTR affect frataxin expression in Friedreich ataxia.
    Bandiera S; Cartault F; Jannot AS; Hatem E; Girard M; Rifai L; Loiseau C; Munnich A; Lyonnet S; Henrion-Caude A
    PLoS One; 2013; 8(1):e54791. PubMed ID: 23382970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.